A serial entrepreneur and a promising drug emerge from failed companies to pursue subsets of obesity patients, with or ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

Dublin-based accessibility start-up Mobility Mojo will receive €4.25m in investment from UK-based equity investor Gresham ...

Robert F. Kennedy Jr., if confirmed as HHS secretary, could help food-as-medicine startups expand with wider government health plan coverage.

Two months after launching Pep2Tango Therapeutics, VC firm Versant Ventures is unveiling another obesity-focused biotech in ...

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

Eli Lilly and Company (NYSE:LLY), a leading global pharmaceutical firm, finds itself at a pivotal juncture as it navigates a ...

Metsera, Inc. aims to raise $275 million in an IPO to fund its clinical-stage biopharma programs targeting obesity and ...

Eli Lilly has agreed a deal to acquire French antibody-drug conjugate (ADC) specialist Mablink, continuing a series of transactions that build its position in what has become one of the fastest ...

Funding Freeze Sets Off New Fight Over Trump’s Vision for His Government President Trump’s order freezing trillions of dollars in federal grants and loans seeks to eliminate all spending on ...

Eli Lilly is a top producer of insulin and antibiotics, and a growing force in weight loss drugs and treatments for Alzheimer’s. The company is also known for drugs to treat diabetes (Trulicity ...

Deepseek logo and rising stock graph are seen in this illustration taken, January 27, 2025. REUTERS/Dado Ruvic/Illustration/File Photo ...